POU5F1 and urinary bladder carcinoma: Additionally, Oct4 has been observed to play a role in the maintenance and progression of tumors in breast cancer [33], nasopharyngeal carcinoma [34], bladder cancer [35], rectal cancer [36], brain cancer [37], and ovarian cancer [38] as well as in chemoresistance in bladder cancer [39].